Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Globus Medical (NYSE:GMED) has scheduled its fourth quarter and full-year 2024 financial results announcement for Thursday, February 20, 2025, after market close. The company will host a conference call with the investment community at 4:30 p.m. Eastern Time on the same day.
Investors can access the conference call through a live webcast on the company's investor relations website. For telephone participation, advance registration is required through a provided link, after which participants will receive dial-in details and unique access credentials. An audio archive of the call will be made available on the company's investor website following the event.
Globus Medical (NYSE:GMED) ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per giovedì 20 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica con la comunità degli investitori alle 16:30 ora orientale dello stesso giorno.
Gli investitori possono accedere alla conferenza telefonica tramite una web diretta sul sito web delle relazioni con gli investitori dell'azienda. Per partecipare telefonicamente, è necessaria una registrazione anticipata tramite un link fornito, dopo di che i partecipanti riceveranno i dettagli per la chiamata e le credenziali di accesso uniche. Un archivio audio della chiamata sarà reso disponibile sul sito web degli investitori dell'azienda dopo l'evento.
Globus Medical (NYSE:GMED) ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 20 de febrero de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica con la comunidad de inversionistas a las 4:30 p.m. hora del Este el mismo día.
Los inversionistas pueden acceder a la conferencia telefónica a través de una transmisión web en vivo en el sitio web de relaciones con inversionistas de la compañía. Para participar por teléfono, se requiere una inscripción previa a través de un enlace proporcionado, tras lo cual los participantes recibirán detalles de acceso y credenciales únicas. Un archivo de audio de la llamada estará disponible en el sitio web de inversionistas de la compañía después del evento.
글로버스 메디컬 (NYSE:GMED)은 2025년 2월 20일 목요일 시장 종료 후 2024 회계연도 4분기 및 연간 재무 결과 발표를 예정하고 있습니다. 회사는 같은 날 동부 표준시 기준 오후 4시 30분에 투자자 커뮤니티와의 전화 회의를 주최할 것입니다.
투자자는 회사의 투자자 관계 웹사이트를 통해 생중계되며 회의에 접속할 수 있습니다. 전화로 참여하려면 제공된 링크를 통해 사전 등록이 필요하며, 이후 참가자는 다이얼인 상세 정보와 고유한 접근 자격을 받게 됩니다. 회의가 끝난 후 회사의 투자자 웹사이트에서 통화의 오디오 아카이브를 이용할 수 있습니다.
Globus Medical (NYSE:GMED) a programmé l'annonce de ses résultats financiers du quatrième trimestre et de l'année entière 2024 pour le jeudi 20 février 2025, après la clôture du marché. L'entreprise animera une conférence téléphonique avec la communauté des investisseurs à 16h30, heure de l'Est, le même jour.
Les investisseurs peuvent accéder à la conférence téléphonique via un webcast en direct sur le site web des relations avec les investisseurs de l'entreprise. Pour participer par téléphone, une inscription préalable est requise via un lien fourni, après quoi les participants recevront les détails de connexion et des identifiants d'accès uniques. Un enregistrement audio de l'appel sera disponible sur le site des investisseurs de l'entreprise après l'événement.
Globus Medical (NYSE:GMED) hat die Bekanntgabe der finanziellen Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Donnerstag, den 20. Februar 2025, nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz mit der Investmentgemeinschaft veranstalten.
Investoren können auf die Telefonkonferenz über ein Live-Webcast auf der Investor-Relations-Website des Unternehmens zugreifen. Für die telefonische Teilnahme ist eine vorherige Registrierung über einen bereitgestellten Link erforderlich; danach erhalten die Teilnehmer die Einwahldaten und eindeutigen Zugangsdaten. Ein Audioarchiv des Anrufs wird nach der Veranstaltung auf der Investor-Website des Unternehmens zur Verfügung stehen.
- None.
- None.
AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2024 after the market close on Thursday, February 20, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call on the Investors page of the Globus Medical website.
About Globus Medical, Inc.
Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive business and our ability to successfully integrate and to achieve anticipated synergies with the integration, health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changes and applicable laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contacts:
Investors:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com
Media:
Moran Chavez
Senior Director, Corporate Affairs
Phone: (619) 318-7681
Email: media@globusmedical.com
FAQ
When will Globus Medical (GMED) release Q4 and full-year 2024 earnings?
What time is GMED's Q4 2024 earnings conference call?
How can investors access GMED's Q4 2024 earnings call?
Where can I find GMED's Q4 2024 earnings release?
